Nanomix, Inc., was named today by the editors of Medical Device & Diagnostic Industry (MD&DI;), a Canon Communications LLC publication, as one of the magazine's 50 Companies to Watch. The write-up on Nanomix can be found in the June 2006 issue of MD&DI; (www.devicelink.com/mddi).
Harris & Harris Group is an investor in privately held Nanomix.
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 30 initial private equity investments have been in tiny technology-enabled companies. The Company has 20,756,345 common shares outstanding.
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.TinyTechVC.com.
This news release is subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this news release. Please see the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the websites www.TinyTechVC.com and www.devicelink.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this news release.